These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

679 related items for PubMed ID: 19361557

  • 1. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
    Lane EL, Brundin P, Cenci MA.
    Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
    [Abstract] [Full Text] [Related]

  • 2. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
    Lane EL, Soulet D, Vercammen L, Cenci MA, Brundin P.
    Neurobiol Dis; 2008 Nov; 32(2):220-8. PubMed ID: 18675359
    [Abstract] [Full Text] [Related]

  • 3. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
    Carlsson T, Carta M, Muñoz A, Mattsson B, Winkler C, Kirik D, Björklund A.
    Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
    [Abstract] [Full Text] [Related]

  • 4. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.
    Shin E, Garcia J, Winkler C, Björklund A, Carta M.
    Neurobiol Dis; 2012 Sep; 47(3):393-406. PubMed ID: 22579773
    [Abstract] [Full Text] [Related]

  • 5. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.
    Dupre KB, Eskow KL, Negron G, Bishop C.
    Brain Res; 2007 Jul 16; 1158():135-43. PubMed ID: 17553470
    [Abstract] [Full Text] [Related]

  • 6. Host brain regulation of dopaminergic grafts function: role of the serotonergic and noradrenergic systems in amphetamine-induced responses.
    Muñoz A, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL.
    Synapse; 2003 Jan 16; 47(1):66-76. PubMed ID: 12422375
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
    Agnati LF, Leo G, Vergoni AV, Martínez E, Hockemeyer J, Lluis C, Franco R, Fuxe K, Ferré S.
    Brain Res Bull; 2004 Aug 30; 64(2):155-64. PubMed ID: 15342103
    [Abstract] [Full Text] [Related]

  • 8. Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
    Lane EL, Vercammen L, Cenci MA, Brundin P.
    Exp Neurol; 2009 Sep 30; 219(1):355-8. PubMed ID: 19393238
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.
    Carta M, Carlsson T, Kirik D, Björklund A.
    Brain; 2007 Jul 30; 130(Pt 7):1819-33. PubMed ID: 17452372
    [Abstract] [Full Text] [Related]

  • 11. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
    Quinn M, Mukhida K, Sadi D, Hong M, Mendez I.
    Eur J Neurosci; 2008 Jan 30; 27(1):43-52. PubMed ID: 18093176
    [Abstract] [Full Text] [Related]

  • 12. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
    Georgievska B, Carlsson T, Lacar B, Winkler C, Kirik D.
    Eur J Neurosci; 2004 Dec 30; 20(11):3121-30. PubMed ID: 15579166
    [Abstract] [Full Text] [Related]

  • 13. Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease.
    Carta M, Carlsson T, Muñoz A, Kirik D, Björklund A.
    Mov Disord; 2010 Dec 30; 25 Suppl 1():S174-9. PubMed ID: 20187238
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU, Widmer HR, Spenger C, Meyer M, Seiler RW, Oertel WH, Sautter J.
    Exp Neurol; 2001 Jan 30; 167(1):148-57. PubMed ID: 11161602
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats.
    Steece-Collier K, Collier TJ, Danielson PD, Kurlan R, Yurek DM, Sladek JR.
    Mov Disord; 2003 Dec 30; 18(12):1442-54. PubMed ID: 14673880
    [Abstract] [Full Text] [Related]

  • 18. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
    Yasuhara T, Shingo T, Muraoka K, Kameda M, Agari T, Wen Ji Y, Hayase H, Hamada H, Borlongan CV, Date I.
    Brain Res; 2005 Aug 16; 1053(1-2):10-8. PubMed ID: 16045899
    [Abstract] [Full Text] [Related]

  • 19. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Srinivasan J, Schmidt WJ.
    Behav Brain Res; 2004 May 05; 151(1-2):191-9. PubMed ID: 15084435
    [Abstract] [Full Text] [Related]

  • 20. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
    Dekundy A, Pietraszek M, Schaefer D, Cenci MA, Danysz W.
    Brain Res Bull; 2006 Apr 14; 69(3):318-26. PubMed ID: 16564428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.